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Introduction
The ability to introduce genes into tissues by systemic administration represents an important advance in gene therapy. Thus, there has been increasing attention focused on the development of efficient gene delivery systems and on the elucidation of the mechanisms involved in gene transfer into cells. The most intensively studied gene delivery systems thus far are those involving attenuated or defective virus. [1] [2] [3] [4] Viral vectors are useful for gene transfer into many different organs ex vivo, in which cells are infected with viral particles in culture before reintroducing the cells back into the patients, or in vivo in which the viral vector is administered directly into patients. The major advantage of viral systems is their high efficiency, but their potential drawbacks include the risk of recombination and strong immunogenicity. Therefore, there has been increasing effort focused on the development of nonviral vectors, particularly the use of cationic liposomes as a gene carrier. [5] [6] [7] [8] [9] In fact, many cationic lipids have been synthesized and some of them have undergone clinical trials. [10] [11] [12] [13] In spite of the great potential of the viral and nonviral delivery systems and the demonstrated efficiency in delivering genes into cells in vitro as well as in vivo, evidence has also accumulated for the successful gene transfer in vivo by naked plasmid DNA. Since the first report in 1990 by Wolff and colleagues, 14 who demonstrated a substantial level of gene expression in muscle by intra-
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Received 18 March 1998; accepted 26 June 1998 muscular injection of naked DNA, similar results have since been reported in liver, [15] [16] [17] melanomas in tumor bearing mice, 18, 19 heart, 20 skin 21 and thyroid gland. 22 Gene expression has also been reported in the lung by intratracheal instillation. 23, 24 However, no systematic study so far has been reported to examine the transfection activity of naked DNA in vivo by intravenous administration.
In this study, we have designed a series of experiments to examine the transfectability of cells in the lung by naked DNA via intravenous administration. Using luciferase gene as a reporter, we show that free plasmid DNA intravenously administered generally results in a low level of gene expression in the lung. However, injection of plasmid DNA into animals that were preinjected with cationic liposomes composed of either N-(2,3-dioleyloxy) propyl-N,N,N-trimethylamonium chloride (DOTMA) or 1,2-dioleoyl-3-trimethylammonium propane chloride (DOTAP) showed a significant level of gene expression, which is correlated with the retention time of DNA in this organ. These findings may provide important information regarding the mechanism involved in DNA-lipid complex-mediated transfection to cells in the lung through systemic administration. The results also suggest a new strategy of transfecting cells in vivo.
Results
Effect of preinjection of cationic liposomes on DNA accumulation and the level of gene expression in the lung A successful gene transfer into cells needs sufficient contact of DNA with the target cells. In order to prevent the rapid transit of plasmid DNA from the lung after tail vein administration, cationic liposomes were injected into animal before the injection of plasmid DNA. Figure 1a shows the dose effect of cationic liposomes on DNA uptake by the lung. DNA was injected into the tail vein 5 min after liposome administration. The amount of DNA in the lung was determined 5 min after DNA injection. As shown in Figure 1a , between two types of cationic liposomes injected, alkyl chain-based lipids (DOTMA and DOTAP) exhibit much higher activity than cholesterol derivatives (DC-Chol and TC-Chol) in retaining the plasmid DNA in the lung. Except for animals preinjected with TC-Chol liposomes, the level of DNA accumulation in the lung was proportional to the dose of cationic liposomes administered. At the highest dose of cationic liposomes used (1050 nmol per mouse), approximately 50-60% of injected DNA was taken up by the lung in animals that received either DOTMA or DOTAP liposomes, compared with about 30% in those animals receiving the same amount of DC-Chol liposomes. Preinjection of TCChol liposomes within the tested dose range did not result in any significant enhancement in DNA uptake by the lung.
The level of gene expression as determined by luciferase activity was examined 8 h after DNA injection. Figure  1b shows that the level of gene expression in the lung correlates to DNA uptake by the lung (Figure 1a) , with an exception for animals preinjected with DC-Chol liposomes. Animals receiving either DOTMA or DOTAP liposomes exhibited similar levels of gene expression. In animals preinjected with either DOTMA or DOTAP liposomes, the level of gene expression appeared to be saturated at the level of 900 nmol cationic lipid per mouse. The highest level of gene expression was around 10 7 RLU per mg of protein from the lung extract, equivalent to approximately 1 ng luciferase protein per mg of extracted protein. The luciferase activity in animals preinjected with either DC-Chol or TC-Chol liposomes was the same as that of control animals preinjected with PBS.
Transfection of cells in lung is mediated by free DNA and does not involve cationic liposomes To demonstrate whether cationic liposomes preinjected play important roles in determining the level of gene expression in the lung, we have developed an in vitro lung culture system. In these experiments, animals were first injected with 900 nmol DOTAP liposomes. At different time-points after the liposome administration, animals were killed and free plasmid DNA was directly injected into the lung through the pulmonary artery. The lung was then cultured in RPMI 1640 medium with 10% FBS under the standard cell culture conditions. The unique feature of this technique is that plasmid DNA, otherwise being washed out of the lung capillary bed in vivo, remained in the lung as the blood circulation through the lung was stopped at the beginning of the experiment. The level of gene expression in the lung was determined 5 h later. Figure 2 shows that plasmid DNA injected into the lung through the pulmonary artery is equally effective in transfecting cells in the lung of the animals with or without preinjection of DOTAP liposomes, suggesting that the cationic liposomes are not involved in facilitating the gene transfer into the cells.
Effect of preinjected cationic liposomes on the retention time of DNA in the lung Theoretically, successful gene transfer to cells in the lung can only occur when the DNA molecules have sufficient time to enter the cells before being washed out of the lung capillaries. Therefore, the retention time of these DNA molecules in the lung is likely to play a critical role in determining the level of gene expression. To determine the effect of cationic liposomes on the retention time of DNA in the lung, 125 I-labeled plasmid DNA was injected to animals 5 min after the injection of 900 nmol cationic liposomes per mouse. Figure 3 shows that the retention time of DNA in the lung varies in different groups of animals. Depending on the types of cationic liposomes preinjected, the retention time of DNA in the lung of animals preinjected with either DOTMA or DOTAP liposomes was significantly longer than that of animals receiving the same amount of either DC-Chol or TC-Chol liposomes. These results suggest that the high level of luciferase activity obtained in animals preinjected with either DOTMA or DOTAP liposomes is not only due to their capability of enhancing the uptake of DNA ( Figure  1a ) but also due to their activity in maintaining the trapped DNA in the lung for a prolonged period of time.
Time-dependent tissue distribution of cationic liposomes and its effect on DNA uptake by different organs and the level of gene expression The time-dependent tissue distribution of cationic liposomes and its effect on the tissue distribution of subsequently injected DNA was investigated using 111 In-DTPA-SA as a lipid marker and 125 I-labeled plasmid DNA.
111 In-DTPA-SA is one of the most commonly used lipid markers for tissue distribution studies and was used in a previous study focusing on the tissue distribution of DC-Chol/DOPE liposomes in mice. 25 Figure 4a shows that there were about equal amounts of liposomes (25% injected dose) taken up by the lung, liver or remained in blood 15 min after tail vein injection. With increasing time, the percentage of injected dose of liposomes in lung and blood decreased, accompanied by an increase in liver uptake. For example, 2 h after liposome administration, approximately 45% of the injected dose was found in the liver while the level in the blood was about 12% and the total in other organs including the lung, spleen, heart and kidneys was approximately 15%. This represents a fivefold decrease in the amount of liposomes in the lung compared with the level at 15 min.
The effect of tissue distribution of liposomes at different time-points on DNA distribution was also examined. In these experiments, 5 min before animals were killed, 25 g of plasmid DNA containing trace amounts of 125 Ilabeled pCMV-Luc plasmid DNA were intravenously injected into animals preinjected with DOTMA liposomes. The radioactivity of 125 I-labeled plasmid DNA in different organs was then determined. Therefore, the tissue distribution of DNA summarized in Figure 4b represents the level of DNA in each organ 5 min after the injection of DNA. It is evident from the data in Figure  4b , that the DNA distribution is significantly affected by the tissue distribution of liposomes. For example, 15 min after the injection of DOTMA liposomes, over 55% of injected plasmid DNA was trapped in the lung compared with only 10% in the blood and less than 5% in other organs including the spleen, liver, heart and kidneys. Such a distribution pattern at this time-point was quite different from that of cationic liposomes (Figure 4a ). This would suggest that about 20% of cationic liposomes in the lung had retained over 55% of injected DNA. However, at the later time when the tissue distribution of cationic liposomes had changed, the pattern of DNA distribution was also changed. The general pattern observed is that the amount of DNA found in the lung decreases when the DNA was injected into animals at a later time. The liver uptake increases with time and so does the blood level. Figure 4c shows the level of luciferase activity in different organs that resulted from injection of 25 g pCMVLuc plasmid per mouse at different time-points after DOTMA liposome administration. Gene expression was determined 8 h after DNA administration. Data show that the transfection activity of free DNA is strongly dependent on the time when DNA was injected. Injection 
Characterization of gene expression
Characterization of the level of gene expression as a function of DNA dose as well as time was carried out. The dose-response curve, as shown in Figure 5 , suggests that although the level of gene expression in all organs increases with an increase of the amount of DNA injected, the level of luciferase activity in the lung appeared to be saturated at 25-50 g DNA per mouse, when each animal received 900 nmol of DOTMA liposomes.
Persistence of gene expression in the lung was examined in animals receiving 25 g of DNA after intravenous administration of DOTMA liposomes. Figure 6 shows that gene expression in transfected cells in the lung is transient. Four days after DNA administration, the level of luciferase activity in the lung had decreased to approximately 0.1% of the level at 8 h. Significant decreases in luciferase activity were also apparent in other organs including spleen, liver, heart and kidney.
Discussion
One of the major differences between in vitro and in vivo transfection is that the interaction of transfection reagent with cells in vivo occurs in a more dynamic environment due to rapid blood flow. This might be one of the main reasons that it is much harder to transfect cells in vivo than in vitro, especially by systemic administration. In the case of naked DNA-mediated in vivo transfection, DNA
Figure 5 DNA dose-response curve. Various amount of pCMV-Luc plasmid DNA was injected into animals 5 min after the administration of 900 nmol of DOTMA liposomes. Luciferase activity in lung ( ), spleen ( ), heart ( ), liver ( and kidney ( ) was determined 8 h after DNA administration. Error bars represent s.e.m. from three mice.
molecules, once injected, are first diluted and then carried away by the blood. Theoretically, unless a special mechanism is provided to hold them to the cell surface, it will be difficult for these DNA molecules to enter a cell and have the encoded gene expressed. Therefore, methods that can minimize the flushing effect of blood in vivo will significantly enhance DNA transfection efficiency. By preinjecting cationic liposomes into animals to prolong the retention time of subsequently injected DNA in the lung, we demonstrated in this study that cells in the lung 
min after tail vein injection of 900 nmol of DOTMA liposomes. Lung ( ), spleen ( ), heart ( ), liver ( ) and kidney ( ). Error bars represent s.e.m. from three mice.
can be effectively transfected by naked DNA. The level of gene expression is determined by the level and retention time of DNA in the lung (Figures 1, 3 and 4) . Results from the experiments designed to characterize the pattern of gene expression show that the level of gene expression is saturable ( Figure 5 ) and gene expression is transient ( Figure 6 ).
Cationic liposomes were chosen to trap DNA in the lung since these types of liposomes are known to form aggregates upon exposure to blood or serum due to the electrostatic interactions between the positively charged liposomes and negatively charged blood components, such as serum proteins. When cationic liposomes are injected into blood, a large number of cationic liposomes are brought together by serum proteins due to the excess amount of cationic liposomes at the injection site. These aggregates are likely to be trapped in the lung when passing through the lung capillary bed where the diameters of capillaries are relatively small and the blood flow is slower. Therefore, subsequently injected plasmid DNA, otherwise easily flowing through the lung capillaries, is retained in the lung for an extended period. However, due to the presence of a large excess of negatively charged components in the blood, the trapping of cationic liposomes in the lung is not permanent. The size of cationic liposome aggregates originally trapped in the lung capillary bed will become smaller with an increase of time as more negatively charged blood components bind to each cationic liposome. As a result, the smaller aggregates are washed out of the lung endothelial bed, resulting in a decreased level in the lung. This may be the reason that the level of DNA uptake by the lung was much lower when DNA was injected to animals at later time-points after liposome injection (Figure 4) . Alternatively, cationic liposomes may also be trapped in the lung by the electrostatic interaction between the negatively charged surface of the lung endothelium and the not fully neutralized positive charges on the liposomes. The bound liposomes will then retard the flow rate of subsequently injected DNA molecules in the lung, resulting in a successful gene transfer to the endothelial cells.
It is worth noting that not all types of cationic liposomes are capable of retaining DNA in the lung. Among two types of cationic liposomes tested, cationic liposomes derived from cholesterol, regardless of the head group structure, were not capable of efficiently retaining DNA in the lung. In contrast, cationic liposomes containing the alkyl chains as the hydrophobic domain exhibited good activity (Figures 1 and 3) . It is possible that liposomes composed of cholesterol-based cationic lipid are more easily neutralized by blood components than those composed of either DOTMA or DOTAP, and therefore are washed out of the lung more rapidly. Consequently, plasmid DNA injected at later time-points was not retained in the lung. Alternatively, due to the fact that liposomal structure in the blood can be destroyed by the process of lipid transfer from cationic liposomes to endogenous lipid particles in blood such as HDL, LDL or others, it is also possible that cholesterol-based cationic liposomes are more easily solubilized by these endogenous lipid particles than those with alkyl chains as the hydrophobic anchor. Thus, liposomes that are more easily solubilized in the blood will quickly pass through the lung without trapping subsequently injected DNA. However, it is also important to realize that higher liposome accumulation in the lung does not necessarily result in a high level of DNA accumulation and a high level of gene expression. For example, about 30-35% of the injected dose of large size liposomes composed of PC/Chol/PS (10:5:1, molar ratio, MLV, d Ͼ 1.6 m) were found in the lung at 10 min after intravenous injection. Although such a level remains for at least 2 h, neither DNA accumulation nor gene expression in the lung show any increase following sequential injection of DNA (data not shown).
For alkyl chain-based cationic liposomes, the transfection efficiency obtained by injection of free DNA into animals described in this communication is similar, with regard to the level and the patterns of gene expression, to that of animals transfected with DNA-liposome complexes. 26 While additional experiments are needed to exclude the possibility that a specific DNA-liposome complex structure is essential for successful transfection, data in Figure 2 introduce the possibility that gene expression in the lung obtained by intravenous injection of DNA-liposome complexes may result from free DNAmediated transfection and may not require a special structure of DNA-lipid complexes, as suggested by some previous studies. [27] [28] [29] While it is evident that free DNA is capable of being taken up and encoded gene is expressed by cells in the lung, more experiments are needed to confirm whether the cells transfected are endothelial cells lining the capillary wall of the lung, as suggested by previous studies using DNA-liposome complexes. 26 It will also be important to know whether cells in other organs can also be efficiently transfected by naked DNA if they are maintained in contact with cells for a prolonged period of time. In fact, a high level of gene expression obtained in other organs such as spleen, liver, heart and kidneys at a higher DNA dose, as shown in Figure 5 , supports such a possibility. Studies are needed to elucidate the mech-anisms underlying naked DNA-mediated transfection and to obtain fundamental information with regard to the process in which DNA is transferred across both the plasma and nuclear membranes in a cell.
In summary, using mouse lung as a model, we demonstrated in this study that successful gene transfer can be achieved by intravenous administration of free DNA. To our knowledge, this is the first time that a significant level of gene expression has been obtained in vivo by naked plasmid DNA via intravenous administration. The data show that free DNA can be effective in transfecting cells in vivo if they can be maintained in contact with the target cells for an extended period of time. Our data also suggest that prolonging the interaction time of DNA with cells in vivo may be an important strategy to be considered for future developments. Cationic liposome preparation Cationic liposomes were prepared by a method of extrusion using Invitrogen Extrusion Device (Invitrogen, Ottawa, Canada). In brief, cationic lipids (10 mol cationic lipids) in chloroform were dried under a stream of N 2 gas and vacuum-desiccated for a minimum of 2 h to remove residual amounts of organic solvent. The dried lipid films were hydrated in PBS (pH 7.4) at lipid concentration of 15 mm for a minimum of 30 min at room temperature. The lipid suspension was then extruded 15 times through two layers of nucleopore membrane with a pore size of 0.6 m. The average diameter of liposomes was around 400 nm as measured by light scattering using a submicron particle analyzer (Particle Sizing Systems, Santa Barbara, CA, USA). The multilamellar structure of the cationic liposomes used was confirmed by freezefracture electron microscopy. To label cationic liposomes, a trace amount of 111 In-labeled DTPA-SA was added to cationic lipid at the beginning of liposome preparation.
Materials and methods
Iodination of plasmid DNA Iodination of plasmid DNA was performed as described previously. 32 In brief, 2 mCi carrier-free Na In vivo transfection Animals were first injected with cationic liposomes in 100 l PBS, pH 7.4 and subsequently free plasmid DNA (pCMV-Luc, in 200 l PBS, pH 7.4) via the tail vein with different time intervals between the two injections. Unless otherwise specified, animals were killed 8 h after injection of plasmid DNA. The lung and other organs including the spleen, liver, heart and kidney were dissected. Lysis buffer (0.1 m Tris-HCl, 2 mm EDTA and 0.1% Triton X-100, pH 7.8) was added at a volume to weight ratio of 4 l/mg of the collected organs except for liver to which 5 l of lysis buffer per mg of liver was used. Each organ was homogenized for 15-20 s with the Tissue Tearor (maximal speed) and the homogenate was then centrifuged in a microcentrifuge for 10 min at 10 000 g at 4°C. A 10 l aliquot of the supernatant (containing about 200 g total protein) was used for luciferase activity assay using a kit purchased from Promega (Madison, WI, USA) and a luminometer (Autolumat LB953; EG & G, Berthold, Germany). Protein concentration of each tissue extract was determined by a standard protein assay (Bradford reagent from BioRad, Hercules, CA, USA). Luciferase activity in each organ was normalized to the relative light unit (RLU) per mg of extracted protein.
Transfection of mouse lung in vitro
One hundred l of DOTAP liposomes containing 900 nmol total lipids were injected into each mouse through the tail vein. Animals were anaesthetized at 5, 30 and 60 min, respectively, by i.p. injection of 0.6 ml saline containing 12 mg 2,2,2-tribromoethanol. Ten units of heparin in 100 l were then injected to animals via the tail vein to prevent blood clotting. A catheter was then inserted into the pulmonary artery to block the blood flow from the heart to the lung and 100 l of DNA solution containing 50 g of plasmid DNA were injected into the lung through the catheter. A cut was made right before the injection of DNA at the left ventricle of the heart to make the outlet open. The whole lung was then dissected from the animal and cultured in a 12-well plate containing 2 ml of RPMI 1640 medium supplemented with 10% fetal bovine serum (FBS) for 5 h in a regular incubator (37°C, 5% CO 2 ). Lysis buffer was then added to the lung after removing the culture medium and the level of gene expression in the lung was determined by the standard luciferase assay as described in the previous section. In radioactivity in each organ was measured in a gamma counter. The radioactivity in the blood was estimated with the assumption that the total blood in mouse equals to 7.3% of total body weight. 33 The blood contamination in each organ was corrected using correction factors established from tissue distribution studies of 51 Cr-labeled red blood cells in mouse. 34 
